Fundamental Analysis of POXEL SA(EPA:POXEL) stock

Fundamental Rating

Overall POXEL gets a fundamental rating of 1 out of 10. We evaluated POXEL against 76 industry peers in the Biotechnology industry. Both the profitability and financial health of POXEL have multiple concerns. POXEL is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

POXEL had negative earnings in the past year.

In the past year POXEL has reported a negative cash flow from operations.

POXEL had negative earnings in 4 of the past 5 years.

POXEL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of POXEL (-345.44%) is worse than 92.96% of its industry peers.

		Industry Rank	Sector Rank
ROA	-345.44%
ROE	N/A
ROIC	N/A

ROA(3y)-60.88%

ROA(5y)-43.4%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of POXEL (0.13%) is comparable to the rest of the industry.

The Profit Margin and Operating Margin are not available for POXEL so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	0.13%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

POXEL does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, POXEL has more shares outstanding

The number of shares outstanding for POXEL has been increased compared to 5 years ago.

POXEL has a worse debt/assets ratio than last year.

2.2 Solvency

POXEL has an Altman-Z score of -13.38. This is a bad value and indicates that POXEL is not financially healthy and even has some risk of bankruptcy.

POXEL's Altman-Z score of -13.38 is on the low side compared to the rest of the industry. POXEL is outperformed by 87.32% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-13.38

ROIC/WACCN/A

WACC7.55%

2.3 Liquidity

POXEL has a Current Ratio of 0.77. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of POXEL (0.77) is worse than 87.32% of its industry peers.

A Quick Ratio of 0.77 indicates that POXEL may have some problems paying its short term obligations.

With a Quick ratio value of 0.77, POXEL is not doing good in the industry: 83.10% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.77
Quick Ratio	0.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for POXEL have decreased strongly by -42.62% in the last year.

The Revenue has grown by 650.49% in the past year. This is a very strong growth!

POXEL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -33.77% yearly.

EPS 1Y (TTM)-42.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-78.52%

Revenue 1Y (TTM)650.49%

Revenue growth 3Y-70.61%

Revenue growth 5Y-33.77%

Sales Q2Q%509.64%

3.2 Future

The Earnings Per Share is expected to decrease by -8.92% on average over the next years.

The Revenue is expected to grow by 86.16% on average over the next years. This is a very strong growth

EPS Next Y39.72%

EPS Next 2Y2.27%

EPS Next 3Y-1.77%

EPS Next 5Y-8.92%

Revenue Next Year-49.6%

Revenue Next 2Y322.98%

Revenue Next 3Y54.02%

Revenue Next 5Y86.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

POXEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year POXEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y2.27%

EPS Next 3Y-1.77%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

POXEL does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

POXEL SA

EPA:POXEL (9/6/2024, 7:00:00 PM)

0.56

-0.01 (-1.06%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap29.40M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-345.44%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	0.13%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.77
Quick Ratio	0.77
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-42.62%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y39.72%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)650.49%

Revenue growth 3Y-70.61%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

POXEL SA (POXEL.PA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens